PMID: 9166392Jan 1, 1997Paper

Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
M H KomulainenS Saarikoski

Abstract

The study was designed to examine the effect of hormone replacement therapy (HRT) and low-dose bone loss in non-osteoporotic early postmenopausal women and to determine whether Vit D supplementation can give additional benefit to an already optimized estrogen regimen. The effects of HRT and Vit D on bone mineral density (BMD) were studied in postmenopausal women in a 2.5-year randomized placebo-controlled study. The study population was a subgroup of the Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) (n = 13100). A total of 464 early postmenopausal women were randomized to four groups: (1) HRT (a sequential combination of 2 mg estradiol valerate and 1 mg cyproterone acetate (E2Val/CPA); (2) vitamin D3 (cholecalciferol, 300 IU/day); (3) HRT + Vit D; and (4) placebo (calcium lactate; 93 mg Ca2+/day). Lumbar (L1-4) and femoral neck BMD were determined by dual-energy X-ray absorptiometry before and after 2.5 years of treatment. After 2.5 years, lumbar BMD had increased by 1.8% in the HRT group (p > 0.001) and by 1.4% in the HRT + Vit D group (p = 0.002), whereas lumbar BMD had decreased by 3.5% (p < 0.001) in the Vit D group and by 3.7% (p < 0.001) in the placebo group. The loss of femoral neck BMD was lower in the H...Continue Reading

References

Dec 3, 1992·The New England Journal of Medicine·M C ChapuyP J Meunier
May 1, 1992·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H KrögerA Kotaniemi
Sep 27, 1990·The New England Journal of Medicine·B Dawson-HughesS Tannenbaum
Oct 1, 1988·The Journal of Clinical Endocrinology and Metabolism·P LipsW J van der Vijgh
Apr 1, 1995·The Journal of Clinical Endocrinology and Metabolism·M E OomsP Lips
Feb 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·H KrögerS Saarikoski
Jan 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M E OomsH A Valkenburg
Oct 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J M PouillesC Ribot
Sep 23, 2010·Cancer Causes & Control : CCC·T HirvonenJ Virtamo

❮ Previous
Next ❯

Citations

Jul 1, 2006·Environmental Health and Preventive Medicine·Kazutoshi Nakamura, Masayuki Iki
Jan 9, 1999·Maturitas·C Netelenbos
Jul 21, 1998·Endocrinology and Metabolism Clinics of North America·I R Reid
Nov 2, 2002·Journal of the American Geriatrics Society·Theresa J AllainCaje F Moniz
Jun 26, 1998·Journal of Clinical Laser Medicine & Surgery
Dec 29, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·T SalménP H Mäenpää
Mar 7, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·T SalménP H Mäenpää
Jun 29, 2005·Treatments in Endocrinology·Aparna MahakalaMichael Kleerekoper
Jan 14, 2010·Clinical Pharmacokinetics·Teun M PostMeindert Danhof
Aug 21, 2007·Gynécologie, obstétrique & fertilité·J Berdah
May 20, 2003·Acta Obstetricia Et Gynecologica Scandinavica·Marjo Tuppurainen
Aug 9, 2003·Expert Opinion on Drug Safety·Ian R Reid
May 1, 2004·American Journal of Obstetrics and Gynecology·Michelle P Warren
Feb 6, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Timo SalménPekka H Mäenpää
Jan 15, 2014·The Cochrane Database of Systematic Reviews·Goran BjelakovicChristian Gluud
May 12, 2005·Human Genetics·S SchmidtA Weise
Aug 31, 2002·Endocrine Reviews·George WellsUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Jun 24, 2014·The Cochrane Database of Systematic Reviews·Goran BjelakovicChristian Gluud
Apr 30, 2003·The American Journal of Clinical Nutrition·Lucy CooperBruce G Robinson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.